Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6111 USD | +0.18% | -2.83% | +79.63% |
May. 24 | Monopar Therapeutics Names Karthik Radhakrishnan as CFO | MT |
May. 24 | Monopar Therapeutics Inc. Announces CFO Changes | CI |
Evolution of the average Target Price on Monopar Therapeutics Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Monopar Therapeutics Inc.
JonesTrading Institutional Services | |
HC Wainwright | |
Maxim | |
EF Hutton | |
Roth MKM | |
Roth Capital Partners |
EPS Revisions
- Stock Market
- Equities
- MNPR Stock
- Consensus Monopar Therapeutics Inc.